Pennant group director JoAnne Stringfield sells $17,037 in stock

JoAnne Stringfield, a director at Pennant Group, Inc. (NASDAQ:PNTG), recently sold a portion of her holdings in the company. The healthcare services provider, currently valued at $929 million, has seen volatile trading patterns according to InvestingPro data, with shares trading between $20.78 and $37.13 over the past 52 weeks. The transaction, which took place on May 1, 2025, involved the sale of 665 shares of common stock at a price of $25.62 per share, totaling $17,037. This sale was conducted under a Rule 10b5-1 trading plan, which Stringfield adopted in November 2024. Following this transaction, she retains ownership of 30,275 shares in the company. With the stock trading at a P/E ratio of 32.5, InvestingPro subscribers can access comprehensive insider trading analysis and 8 additional key insights about PNTG’s valuation metrics.

In other recent news, Pennant Group Inc . reported its fourth-quarter 2024 earnings, with adjusted earnings per share (EPS) of $0.24, slightly missing the forecast of $0.25. However, the company exceeded revenue expectations, reporting $188.9 million against a forecast of $186.05 million. For the full year, Pennant Group’s revenue grew by 27.6% to $695.2 million, with strong performances in the Home Health and Hospice segments. The company projects 2025 revenue between $800 million and $865 million, with adjusted EPS expected to range from $1.03 to $1.11.

Additionally, Pennant Group has expanded its presence in Arizona by acquiring a senior living community, adding 128 units to its operations in the state. This marks the company’s first real estate purchase of the year and is part of a broader strategy to increase its footprint in the senior living sector. The acquisition aligns with Pennant’s mission to provide quality care for seniors.

In terms of analyst insights, Stephens noted the company’s focus on leadership development and operational efficiency as key drivers for future growth. The Pennant Group also faces challenges, such as potential legislative changes affecting Medicaid funding and market saturation in certain areas. Despite these challenges, the company remains optimistic about its growth prospects, with plans to continue expanding through acquisitions and strategic partnerships.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.